rs770202940

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_004006.3(DMD):​c.1159A>G​(p.Met387Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000604 in 1,208,621 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 22 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M387R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000036 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.000063 ( 0 hom. 21 hem. )

Consequence

DMD
NM_004006.3 missense

Scores

3
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 2.16

Publications

0 publications found
Variant links:
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]
DMD Gene-Disease associations (from GenCC):
  • Becker muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • dilated cardiomyopathy 3B
    Inheritance: XL Classification: DEFINITIVE Submitted by: Ambry Genetics
  • Duchenne and Becker muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • Duchenne muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • progressive muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.19817841).
BP6
Variant X-32644304-T-C is Benign according to our data. Variant chrX-32644304-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 239598.
BS2
High AC in GnomAdExome4 at 69 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DMDNM_004006.3 linkc.1159A>G p.Met387Val missense_variant Exon 11 of 79 ENST00000357033.9 NP_003997.2 P11532

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DMDENST00000357033.9 linkc.1159A>G p.Met387Val missense_variant Exon 11 of 79 1 NM_004006.3 ENSP00000354923.3 A0A075B6G3

Frequencies

GnomAD3 genomes
AF:
0.0000360
AC:
4
AN:
111253
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000754
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000328
AC:
6
AN:
182860
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000736
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000629
AC:
69
AN:
1097368
Hom.:
0
Cov.:
30
AF XY:
0.0000579
AC XY:
21
AN XY:
362832
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26386
American (AMR)
AF:
0.00
AC:
0
AN:
35185
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19364
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30185
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54123
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40485
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4134
European-Non Finnish (NFE)
AF:
0.0000796
AC:
67
AN:
841443
Other (OTH)
AF:
0.0000434
AC:
2
AN:
46063
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000360
AC:
4
AN:
111253
Hom.:
0
Cov.:
23
AF XY:
0.0000299
AC XY:
1
AN XY:
33449
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30577
American (AMR)
AF:
0.00
AC:
0
AN:
10374
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2637
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3530
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2637
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6011
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
238
European-Non Finnish (NFE)
AF:
0.0000754
AC:
4
AN:
53058
Other (OTH)
AF:
0.00
AC:
0
AN:
1504
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.542
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000214
Hom.:
1
Bravo
AF:
0.0000113
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ExAC
AF:
0.00000824
AC:
1
EpiCase
AF:
0.000109
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Jan 14, 2016
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 22, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Mar 06, 2017
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Met387Val variant has not been previously reported in individuals with myo pathy, but has been reported in ClinVar (Variation ID# 239598). This variant has been identified in 6/90307 European chromosomes, including one hemizygote, by t he Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs770202940). The affected amino acid is not well conserved in evolution with 5 fish species carrying a valine (Val), but computational prediction tools do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.Met387Val variant is uncertain. -

Cardiovascular phenotype Uncertain:1
Feb 06, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.M387V variant (also known as c.1159A>G), located in coding exon 11 of the DMD gene, results from an A to G substitution at nucleotide position 1159. The methionine at codon 387 is replaced by valine, an amino acid with highly similar properties. Based on data from gnomAD, the G allele has an overall frequency of <0.01% (8/204746) total alleles studied, with 1 hemizygote(s) observed. The highest observed frequency was <0.01% (8/92345) of European (non-Finnish) alleles. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Duchenne muscular dystrophy Benign:1
Oct 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
20
DANN
Benign
0.93
DEOGEN2
Benign
0.28
.;T;.;.;T
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.90
D;.;D;D;D
M_CAP
Benign
0.070
D
MetaRNN
Benign
0.20
T;T;T;T;T
MetaSVM
Benign
-1.0
T
PhyloP100
2.2
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-1.5
.;N;.;N;N
REVEL
Benign
0.034
Sift
Benign
0.44
.;T;.;T;T
Sift4G
Benign
0.40
T;T;T;T;T
Polyphen
0.14, 0.021
.;B;.;.;B
Vest4
0.29
MutPred
0.29
.;.;Loss of disorder (P = 0.159);Loss of disorder (P = 0.159);.;
MVP
0.64
MPC
0.022
ClinPred
0.061
T
GERP RS
5.9
gMVP
0.19
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs770202940; hg19: chrX-32662421; API